title: Successful treatment with tocilizumab of pericarditis associated with rheumatoid arthritis.
abstract: Rheumatoid arthritis (RA) is a systemic inflammatory disease often complicated by vasculitis. Pericarditis is a serious complication caused by vasculitis, resulting in retention of pericardial effusion that sometimes induces cardiac tamponade. We report a patient with RA in whom pericarditis improved after tocilizumab administration. A male patient was diagnosed with RA and chronic renal failure in 1980 and was treated with salazosulfapyridine, but disease activity remained high. In January 2012, at the age of 73 years, he developed organizing pneumonia as a complication and was admitted to our hospital. Treatment with prednisolone 30 mg/day was initiated. However, 20 days after initiation of treatment, chest pain and palpitation developed, and chest computed tomography (CT) and echocardiography (ECG) revealed retention of pericardial effusion without cardiac tamponade. Rheumatoid nodules and interstitial pneumonia were also observed, and serum C3 level was decreased. A diagnosis of pericarditis caused by vasculitis was made based on these findings, and tocilizumab 8 mg/kg was administered. His symptoms improved gradually, and chest CT and ECG showed no pericardial effusion after about 3 weeks. No adverse effects of tocilizumab were observed during the clinical course. Although there are only a few reports of the effects of tocilizumab on vasculitis associated with RA, tocilizumab administration appears worthwhile in RA patients with vasculitis who do not respond to conventional treatment.
authors: Internal Medicine, Arisawa General Hospital , Osaka , Japan.
authors: Shuzo
authors: S
authors: Yoshida
authors: Tohru
authors: T
authors: Takeuchi
authors: Hideaki
authors: H
authors: Sawaki
authors: Tamaki
authors: T
authors: Imai
authors: Shigeki
authors: S
authors: Makino
authors: Toshiaki
authors: T
authors: Hanafusa
mesh_terms: D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications*; D002305:Cardiac Tamponade / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D010493:Pericarditis / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C502936:tocilizumab
keywords: Pericarditis; Rheumatoid arthritis; Tocilizumab; Vasculitis